EMA recommends switch to OTC for EllaOne

21 November 2014 - Deborah Wilkes

Archived

HRA Pharma's emergency contraceptive EllaOne (ulipristal acetate) is set to be switched from prescription to non-prescription status throughout the European Union.

Click tags below for more information on topics:

HRA Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: